US4657898A
Expired / Lapsed
US
⏱️ 0.0 years remaining
N6 -substituted adenosines and method of use
Assignee: Warner Lambert Co LLC
•
Filing: 1985-07-18
•
Granted: 1987-04-14
•
Expires: 2005-07-18
Abstract
Abstract N 6 -Substituted diarylalkyladenosines and pharmaceutically acceptable acid addition salts having highly desirable central nervous system and cardiovascular properties, processes for their manufacture and pharmaceutical compositions and methods for using said compounds and compositions are described.
Inventors
- 👤 James A. Bristol
- 👤 Walter H. Moos
- 👤 Bharat Trivedi
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 04:06
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/16; C07H19/20; C07H19/22
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
282 words
A compound of the formula ##STR6## or a pharmaceutically acceptable addition salt thereof, wherein R 1 is hydrogen or lower alkyl; Ar and Ar 1 are each independently phenyl, phenyl substituted by halogen, hydroxy, thiol, lower alkoxy, lower thioalkoxy, lower alkanoyloxy, lower alkyl, nitro, amino, low S(O) n , -alkyl in which n is zero, one, or two, sulfonamide or trifluoromethyl, or 2-, 3-, or 4-pyridyl, 2- or 3-thienyl or -furanyl; A is straight or branched alkylene of one to eight carbon atoms which may be interrupted by oxygen, sulfur, or NH between two and seven carbons of the alkylene chain; X is hydrogen, hydroxy, lower alkyl, lower carboalkoxy, or lower alkanoyloxy; Y is hydrogen, halogen, --NR 2 R 3 , --OR 2 , or --SR, in which R 2 and R 3 are independently hydrogen, lower alkyl or phenyl lower alkyl; Z is hydrogen or halogen; R 2 ' and R 3 ' are each independently hydrogen, alkanoyl having two to twelve carbon atoms in a straight or branched alkyl chain which may be substituted by amino, benzoyl or benzoyl substituted by lower alkyl, lower alkoxy, halogen, or trifluoromethyl; R 2 ' and R 3 ' may be linked together to form a five-membered alkylidene ring having a total of up to 20 carbons, and R 5 ' is hydrogen; alkanoyl having two to twelve carbons in a straight or branched alkyl chain which may be substituted by amino, benzoyl or benzoyl substituted by lower alkyl, lower alkoxy, halogen, or trifluromethyl; phosphate; hydrogen phosphate; dihydrogen phosphate; an alkali or dialkali or dialkali metal phosphate; with the overall proviso that A cannot be a branched alkylene of two to eight carbon atoms.
Claim 2
Dependent Claim
282 words
A compound of the formula ##STR6## or a pharmaceutically acceptable addition salt thereof, wherein R 1 is hydrogen or lower alkyl; Ar and Ar 1 are each independently phenyl, phenyl substituted by halogen, hydroxy, thiol, lower alkoxy, lower thioalkoxy, lower alkanoyloxy, lower alkyl, nitro, amino, low S(O) n , -alkyl in which n is zero, one, or two, sulfonamide or trifluoromethyl, or 2-, 3-, or 4-pyridyl, 2- or 3-thienyl or -furanyl; A is straight or branched alkylene of one to eight carbon atoms which may be interrupted by oxygen, sulfur, or NH between two and seven carbons of the alkylene chain; X is hydrogen, hydroxy, lower alkyl, lower carboalkoxy, or lower alkanoyloxy; Y is hydrogen, halogen, --NR 2 R 3 , --OR 2 , or --SR, in which R 2 and R 3 are independently hydrogen, lower alkyl or phenyl lower alkyl; Z is hydrogen or halogen; R 2 ' and R 3 ' are each independently hydrogen, alkanoyl having two to twelve carbon atoms in a straight or branched alkyl chain which may be substituted by amino, benzoyl or benzoyl substituted by lower alkyl, lower alkoxy, halogen, or trifluoromethyl; R 2 ' and R 3 ' may be linked together to form a five-membered alkylidene ring having a total of up to 20 carbons, and R 5 ' is hydrogen; alkanoyl having two to twelve carbons in a straight or branched alkyl chain which may be substituted by amino, benzoyl or benzoyl substituted by lower alkyl, lower alkoxy, halogen, or trifluromethyl; phosphate; hydrogen phosphate; dihydrogen phosphate; an alkali or dialkali or dialkali metal phosphate; with the overall proviso that A cannot be a branched alkylene of two to eight carbon atoms.
Claim 3
Dependent Claim
53 words
A compound as claimed in claim 1, wherein R 1 and X are hydrogen or methyl; R 2 ' and R 3 ' are hydrogen, acetyl, benzoyl or when taken together form isopropylidene; R 5 ' is hydrogen, phosphate, hydrogen phosphate, dihydrogen phosphate, sodium phosphate or disodium phosphate; Z is hydrogen or fluorine.
Claim 4
Dependent Claim
23 words
A compound as claimed in claim 2, wherein R 1 ', R 2 ',R 3 ',R 5 ', X, and Z are hydrogen.
Claim 5
Dependent Claim
32 words
A compound as claimed in claim 3, wherein Y is hydrogen, halogen or --NR 2 R 3 where R 2 and R 3 are independently hydrogen, lower alkyl or phenyl lower alkyl.
Claim 6
Dependent Claim
27 words
A compound as claimed in claim 4, wherein Y is hydrogen, chlorine or amino and A is straight of branched alkylene from 1 to 4 carbon atoms.
Claim 7
Dependent Claim
18 words
A compound as claimed in claim 5, wherein A is methylene, and Ar and Ar 1 are phenyl.
Claim 8
Dependent Claim
12 words
A compound as claimed in claim 6 and being N 6 -(2,2-diphenylethyl)adenosine.
Claim 9
Dependent Claim
12 words
A compound as claimed in claim 5 and being N 6 -(3,3-diphenylpropyl)adenosine.
Claim 10
Dependent Claim
12 words
A compound as claimed in claim 6 and being N 6 -(2,2-diphenylethyl)-2-chloroadenosine.
Claim 11
Dependent Claim
12 words
A compound as claimed in claim 6 and being N 6 -(2,2-diphenylethyl)-2-aminoadenosine.
Claim 12
Dependent Claim
12 words
A compound as claimed in claim 5 and being N 6 -(2,2-diphenylpropyl)adenosine.
Claim 13
Dependent Claim
24 words
A pharmaceutical composition comprising a therapeutically effective amount for antipsychotic activity of a compound as claimed in claim 1 and a pharmaceutically acceptable carrier.
Claim 14
Independent Claim
304 words
A method for treating psychosis in a mammal suffering therefrom comprising administering an anti psychotic effective amount to such mammal a compound of the formula ##STR7## or a pharmaceutically acceptable addition salt thereof, wherein R 1 is hydrogen or lower alkyl; Ar and Ar 1 are each independently phenyl phenyl substituted by halogen, hydroxy thiol, lower alkoxy, lower thioalkoxy, lower alkanoyloxy, lower alkyl, nitro, amino, lower S(O) n -alkyl in which n is zero, one, or two, sulfonamide or trifluromenthyl, or 2-, 3-, or 4-pyridyl, 2- or 3-thienyl or -furanyl; A is straight or branched alkylene of one to eight carbon atoms which may be interrupted by oxygen, sulfur, or NH between two and seven carbons of the alkylene chain; X is hydrogen, hydroxy, lower alkyl, lower carboalkoxy, or lower alkanoyloxy; Y is hydrogen, halogen, --NR 2R 3, --OR 2, or --SR 2 in which R 2 and R 3 are independently hydrogen, lower alkyl or phenyl lower alkyl; Z is hydrogen or halogen; R 2 ' and R 3 ' are each independently hydrogen, alkanoyl having two to twelve carbon atoms in a straight or branched alkyl chain which may be substituted by amino, benzoyl or benzoyl substituted by lower alkyl, lower alkoxy, halogen, or trifluromethyl; R 2 ' and R 3 ' may be linked together to from a five-membered alkylidene ring having a total up to 20 carbons, and R 5 ' is hydrogen, alkanoyl having two to twelve carbons in a straight or branched alkyl chain which may be substituted by amino, benzoyl or benzoyl substituted by lower alkyl; lower alkoxy, halogen, or trifluromethyl; phosphate; hydrogen phosphate; dihydrogen phosphate; an alkali or dialkali metal phosphate; ammonium or diammonium phosphate; with the overall proviso that A cannot be a branched alkylene of two to eight carbon atoms in unit dosage forms.
Claim 15
Independent Claim
304 words
A method for treating psychosis in a mammal suffering therefrom comprising administering an anti psychotic effective amount to such mammal a compound of the formula ##STR7## or a pharmaceutically acceptable addition salt thereof, wherein R 1 is hydrogen or lower alkyl; Ar and Ar 1 are each independently phenyl phenyl substituted by halogen, hydroxy thiol, lower alkoxy, lower thioalkoxy, lower alkanoyloxy, lower alkyl, nitro, amino, lower S(O) n -alkyl in which n is zero, one, or two, sulfonamide or trifluromenthyl, or 2-, 3-, or 4-pyridyl, 2- or 3-thienyl or -furanyl; A is straight or branched alkylene of one to eight carbon atoms which may be interrupted by oxygen, sulfur, or NH between two and seven carbons of the alkylene chain; X is hydrogen, hydroxy, lower alkyl, lower carboalkoxy, or lower alkanoyloxy; Y is hydrogen, halogen, --NR 2R 3, --OR 2, or --SR 2 in which R 2 and R 3 are independently hydrogen, lower alkyl or phenyl lower alkyl; Z is hydrogen or halogen; R 2 ' and R 3 ' are each independently hydrogen, alkanoyl having two to twelve carbon atoms in a straight or branched alkyl chain which may be substituted by amino, benzoyl or benzoyl substituted by lower alkyl, lower alkoxy, halogen, or trifluromethyl; R 2 ' and R 3 ' may be linked together to from a five-membered alkylidene ring having a total up to 20 carbons, and R 5 ' is hydrogen, alkanoyl having two to twelve carbons in a straight or branched alkyl chain which may be substituted by amino, benzoyl or benzoyl substituted by lower alkyl; lower alkoxy, halogen, or trifluromethyl; phosphate; hydrogen phosphate; dihydrogen phosphate; an alkali or dialkali metal phosphate; ammonium or diammonium phosphate; with the overall proviso that A cannot be a branched alkylene of two to eight carbon atoms in unit dosage forms.
Claim 16
Dependent Claim
23 words
A pharmaceutical composition for treating psychosis comprising an antipsychotic effective amount of a compound as claimed in claim 1 in unit dosage form.
References Cited (Backward Citations)
US3225029A
Cited
US3845035A
Cited
US3983104A
Cited
US4090021A
Cited
DE2406587A1
Cited
EP0040325A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-04-13 | 1990-10-13 | 1991-04-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-04-13 | 1994-10-13 | 1995-04-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-04-13 | 1998-10-13 | 1999-04-14 | $7700.00 | Window Closed / Lapsed |